The most hand-holdy of the bunch — the intake asked the most questions, but it also felt the most like a clinician was actually reading them, which is the trade I'd make when I'm doing this solo.
Ivím Health
Ranked #3 · Grade B+
The GLP-1 specialist of the group — this is all it does, and it shows. The pricing is genuinely low for both molecules, and the intake stayed focused instead of trying to sell me five other things.
The broadest GLP-1 menu I've found anywhere — brand Zepbound and Wegovy, two GLP-1 pills, and three compounded molecules — from doctors who actually specialise in midlife hormones, with one mandatory $99 fee sitting quietly on top of every price it advertises.
Trimi Health
Ranked #5 · Grade B
The price-first pick: some of the lowest flat, all-inclusive pricing I found, in all 50 states — great if the monthly number is your whole decision and you read the annual-prepay fine print before you sign.
Gala Health
Ranked #6 · Grade B
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it won't name.
Breeze Meds
Ranked #7 · Grade B
A LegitScript-verified compounded option with a named medical team, all-50 coverage, and no subscription — semaglutide starts at $199, though it's one of several near-identical white-label sibling brands.
Knownwell
Ranked #8 · Grade B
The only provider on my list that behaves like an actual doctor's office — in-network with most commercial plans and Medicare, dietitians and coaches built in, and every self-pay price published down to the dose — as long as you can get to a booked appointment every month at the start.
Synergy Rx
Ranked #9 · Grade B
Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.
Telos Rx
Ranked #10 · Grade B
Four flat, posted price points and a written promise your cost won't climb with your dose — a real step up in clarity from what we found last check — undercut by a state list it still won't publish.